Paris, Ile-de-France, France In 1972 was created Apax Partners France, which is appeared as VC. The main office of represented VC is situated in the Paris. The company was established in Europe in France.
Besides, a startup requires to be at the age of 1 and less years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Tourism. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Denmark. Among the various public portfolio startups of the fund, we may underline Genmab
The important activity for fund was in 2012. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. This Apax Partners France works on 16 percentage points more the average amount of lead investments comparing to the other organizations. The increased amount of exits for fund were in 2019. Speaking about the real fund results, this VC is 44 percentage points more often commits exit comparing to other organizations.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the Apax Partners France, startups are often financed by Naxicap Partners, Dansk Erhvervsinvestering, BankInvest Biomedical Venture. The meaningful sponsors for the fund in investment in the same round are EPF Partners, Naxicap Partners, Lion Capital. In the next rounds fund is usually obtained by Naxicap Partners, GlaxoSmithKline.
Related Funds
Funds with similar focus
Discover 5 more decision makers 1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 